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Introduction
Aging is widely held to be the consequence of the accumula-
tion of cellular damage over time (López-Otín et al., 2013). 
In humans, aging is marked by declining tissue function and 
increased susceptibility to diseases such as cancer, diabetes, 
cardiovascular disease, dementia, arthritis, sarcopenia, and 
renal dysfunction. Aging-associated diseases and phenotypes 
frequently manifest on the tissue level yet have their roots in 
molecular and cellular damage (López-Otín et al., 2013).
Most aging research is motivated by the need to under-
stand the process of aging in humans. However, studying aging 
requires observing and perturbing molecules, cells, tissues, and 
systems in organisms over time—requirements that are not fea-
sible in humans. Instead, aging is studied in model systems, 
each of which balances a desire for biological relevance on 
one hand and practicality on the other. Thus, most models of 
aging suffer from key limitations depending on where on this 
spectrum they lie. Organoid culture, especially human organoid 
culture, has the potential to address many of the limitations of 
traditional aging models. By providing organotypic structure 
in an in vitro model, organoids enable the study of aging in 
tissues in a higher-throughput, experimentally accessible man-
ner. These potential advantages may be particularly useful for 
studying emergent signs of aging at the tissue level, clearing the 
way for future human therapies.
Models of aging
The spectrum of aging models. The trade-off between 
relevance to humans and ease of experimentation is a limitation 
in any model, particularly when seeking to develop interven-
tions to limit the effects of human aging. Organoids provide a 
powerful and physiologically relevant means to perform in vitro 
experiments on tissue and on human tissue in particular.
Nonhuman organisms and traditional cell culture have 
been invaluable tools for the study of fundamental aging pro-
cesses, including the Nobel Prize-winning mechanisms of 
telomere regulation and DNA repair (Sancar and Rupp, 1983; 
Greider and Blackburn, 1987; Lindahl, 1993). However, model 
organisms may age in ways not applicable to humans. For ex-
ample, Caenorhabditis elegans has a dauer stage, a stress- and 
aging-resistant larval form. Induction of dauer-like states may 
alter lifespan with questionable correlation to human aging 
(McElwee et al., 2006). In mice, the most common mamma-
lian model organism, important features that affect aging, such 
as immune response, DNA repair, telomerase regulation, and 
telomere length, differ significantly between mice and humans 
(Rangarajan and Weinberg, 2003; Seok et al., 2013). Even 
naked mole rats and blind mole rats, two rodents both renowned 
for their sevenfold-longer lives than laboratory mice, owe their 
longevity to differing molecular mechanisms (Azpurua and 
Seluanov, 2013). Thus, different species, even within the same 
order, have developed distinct mechanisms for controlling lifes-
pan and health span in relatively brief evolutionary time. These 
differences have practical implications. Some of the most prom-
inent diseases of human aging, such as epithelial cancers, car-
diovascular disease, osteoporosis, and Alzheimer’s disease, are 
rare or nonexistent in aged mice, who instead predominantly 
suffer from mesenchymal cancers (Rangarajan and Weinberg, 
2003; Vanhooren and Libert, 2013). Consequently, interven-
tions that reduce susceptibility to human age-related diseases 
may not affect mouse lifespan, and vice versa.
Ultimately, studies in humans are necessary to validate 
therapies for human aging, but ethical, logistical, and financial 
challenges render routine human aging studies infeasible. A 
widely practiced alternative is cell culture, but the correlations 
The biology of aging is challenging to study, particularly 
in humans. As a result, model organisms are used to ap-
proximate the physiological context of aging in humans. 
However, the best model organisms remain expensive 
and time-consuming to use. More importantly, they may 
not reflect directly on the process of aging in people. 
Human cell culture provides an alternative, but many 
functional signs of aging occur at the level of tissues rather 
than cells and are therefore not readily apparent in tradi-
tional cell culture models. Organoids have the potential to 
effectively balance between the strengths and weaknesses 
of traditional models of aging. They have sufficient com-
plexity to capture relevant signs of aging at the molecular, 
cellular, and tissue levels, while presenting an experimen-
tally tractable alternative to animal studies. Organoid sys-
tems have been developed to model many human tissues 
and diseases. Here we provide a perspective on the po-
tential for organoids to serve as models for aging and 
describe how current organoid techniques could be ap-
plied to aging research.
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to human aging may be weak because of the lack of physiolog-
ical context. Many signs of aging, namely those that manifest 
at the tissue and organ level, may be best represented by a more 
complex system. These signs of aging include a breakdown in 
tissue homeostasis, stem cell dysfunction, and susceptibility to 
tissue-specific diseases and cancer (López-Otín et al., 2013).
Although more technically challenging than traditional 
cell culture, organoids provide increased relevance to human 
health via a microenvironment supportive of tissue-specific 
function and physiological cell–cell and cell–matrix interac-
tions. These factors contribute to increased viability of dif-
ficult-to-culture cells, including primary cells and prostate 
tumors (Gao et al., 2014). Moreover, 3D culture improves cell 
type–specific function and gene expression in cells such as 
chondrocytes, hepatocytes, and mammary and kidney epithelial 
cells (Ben-Ze’ev et al., 1988; Astashkina et al., 2012; Caron et 
al., 2012; Simian and Bissell, 2017). As a result, organoids may 
be useful for modeling age-related declines in tissue-specific 
function, such as chondrocyte matrix deposition (Barbero et al., 
2004). Furthermore, age-related pathologies intrinsically linked 
to the ECM, such as osteoarthritis, are well-suited to study in 
a 3D system (Lozito et al., 2013). Organoids may be the most 
practical way to perform aging experiments at this level of com-
plexity, particularly on human tissues.
Practical experiments with organoid models. 
Organoids provide a practical alternative to whole-organism 
studies in mammals. Patient-derived organoids have been scaled 
to high-throughput screens against cystic fibrosis and cancer, 
which would be cost-prohibitive in mice or humans (Dekkers et 
al., 2016; Pauli et al., 2017; Schütte et al., 2017). Demonstrating 
the scalability and high-throughput potential of organoids, Pauli 
et al. (2017) developed patient-derived tumor organoids for 
screening a library of >100 drugs at different concentrations 
and combinations, and Danahay et al. (2015) screened nearly 
5,000 proteins for their effects on basal cell fate 
in human lung organoids.
Improved throughput is made possible not only by larger 
sample sizes but also simpler assays. Some molecular signs of 
aging, such as protein aggregation, oxidation, and glycation, 
can be assayed by nondestructive, high-throughput micros-
copy (Meerwaldt et al., 2004; Chaudhuri et al., 2006; Jung et 
al., 2010). Organoids are far more amenable to live-cell im-
aging than whole organisms, such as mice, and can comple-
ment mouse studies with imaging and perturbations that would 
be otherwise impractical. High-resolution live imaging of 
development, stem cell dynamics, and cancer invasion has been 
demonstrated in several organoid systems (Sato et al., 2011; 
Nguyen-Ngoc et al., 2015).
Finally, manipulating microenvironmental cues and spe-
cific cell populations is more straightforward in organoids than 
model organisms. Organoids are typically embedded in a matrix 
of the investigators’ choice, allowing for increased control over 
its source, composition, and mechanical properties. Cells ac-
quired from tissue can be sorted, modified to delete or express 
specific genes, and expanded before assembly into organoids, 
allowing investigators to build organoids using defined building 
blocks from the bottom up. These organoids enable otherwise 
infeasible studies, such as tissues bearing gene knockouts that 
would be embryonically lethal. Additionally, this strategy al-
lows the construction of organoids composed of specific pro-
portions of cell subpopulations. For example, Sato et al. (2011) 
assembled intestinal organoids from stem cells with or without 
Paneth cells to identify Paneth cells as essential components 
of the intestinal stem cell (ISC) niche, a result previously ob-
scured by incomplete lineage ablation. Moreover, viral vectors 
or transfection allows genetic manipulation of organoids with 
far less time and expense than developing a transgenic mouse 
(Koo et al., 2011). As a result, organoid approaches greatly en-
hance our capacity to study specific cell populations, pheno-
types, and mutations within the context of a tissue. Organoid 
models of aging are in their earliest stages, but promising work, 
discussed in this perspective, has demonstrated their potential 
applicability to aging research.
Studying aging in organoids
Molecular and cellular processes. The genome can be 
damaged through several mechanisms, leading to the acquisi-
tion of genetic and epigenetic changes with age. DNA damage 
activates repair pathways but can also trigger mutations, apop-
tosis, or senescence. These outcomes can lead to aberrant be-
havior and deleterious effects on neighboring cells, such as 
inflammatory senescence-associated signaling (Parrinello et al., 
2005). Epigenetically, aging cells acquire regional hyper- and 
hypomethylation, as well as increased variance in epigenetic 
marks (Jones et al., 2015). These cell-intrinsic aspects of aging 
are preserved in primary cells and tissue-derived organoids 
(Blokzijl et al., 2016).
Glycation, oxidation, and misfolding are foremost among 
molecular damage to proteins during aging. In particular, ECM 
proteins such as collagen, elastin, and crystallin are susceptible 
to nonenzymatic glycation, leading to stiffening of the ECM 
(Singh et al., 2001). Age-associated glycation, as well as altered 
structure, composition, and cross-linking of the ECM, has been 
associated with functional declines in a variety of tissues (Phil-
lip et al., 2015). As matrix is a major component of organoid 
culture, organoids are a natural model for the effects of aged 
ECM on tissue function.
Organoid assays can enable researchers to experimentally 
link aging-associated changes in ECM structure to functional 
consequences. ECM substrates and gels for cell culture have 
been isolated from human and animal tissue (Voytik-Harbin et 
al., 2007; Zhang et al., 2009; O’Brien et al., 2010). Decreased 
cell proliferation and stem cell function have been observed on 
matrices derived from older donors, including Bruch’s mem-
brane and cardiac and skeletal muscle ECM (Gullapalli et al., 
2005; Williams et al., 2014; Stearns-Reider et al., 2017). More 
complex phenotypes can also be linked to ECM source by using 
What is an organoid?
An organoid is a miniature, simplified organ that recreates physiological 
3D tissue structure and cellular composition in vitro. Examples include a 
variety of 3D in vitro culture systems: cultured tissue fragments, tissues 
reconstituted from cultured cells, and tissues grown from stem cells, usu-
ally in the presence of ECM protein. In this perspective, we have broadly 
included examples and influences from several different organotypic cul-
ture systems. The use of organoids reflects the philosophy that the struc-
ture and composition of a tissue is relevant to its function (Simian and 
Bissell, 2017). In practice, organoids are characterized by some if not all 
of the following features:
•	 A physiologically relevant microenvironment
•	 Cells derived from primary tissues, primary cells, or stem 
cells, rather than immortalized cell lines
•	 Cells correctly organized with respect to one another and 
their ECM
•	 Multiple cell types from the original organ
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organoid models. The Schedin group (Lyons et al., 2011) has 
shown that ECM from rats in different reproductive states can 
instruct morphogenesis and invasion of human mammary and 
breast cancer organoids. In addition, several groups have ex-
perimentally modified the ECM via advanced glycation end 
product–mediated cross-linking to mimic ECM aging, demon-
strating aging phenotypes such as skin and cartilage stiffening 
and increased invasiveness (Verzijl et al., 2002; Pageon and As-
selineau, 2005; Rodriguez-Teja et al., 2015).
Chemical damage can also lead to degradation and ag-
gregation of proteins and other biomolecules, such as lipids. 
Protein damage accumulates in the form of carbonylation, 
fragmentation, and cross-linking, whereas lipid peroxidation 
compromises membranes and leads to the accumulation of ox-
idized fatty acids. Oxidation products not only have reduced 
function but are also prone to cross-linking. Together with 
misfolding, age-associated protein oxidation results in prote-
olysis-resistant aggregates both intra- and extracellularly. This 
feature is highly conserved across species; one of the most 
universal signs of aging is the accumulation of intracellular li-
pofuscin lipid-protein aggregates (Jung et al., 2010). Although 
their causal role in pathogenesis is disputed, protein and lip-
id-protein aggregates are prominently associated with central 
nervous system dysfunction, such as the infamous tangles, 
amyloids, and Lewy bodies in neurodegenerative disease, and 
the retinal drusen in age-related macular degeneration (Crabb 
et al., 2002; Caughey and Lansbury, 2003). These late-stage 
manifestations of neurodegenerative pathology may be more 
apparent in 3D culture than in traditional cell culture, where 
secreted proteins diffuse freely into culture media rather than 
accumulate near cells. In a human stem cell–derived model 
of familial Alzheimer’s disease, 3D culture was found to not 
only improve neuronal maturation but also promote tauopathy 
though the accumulation of β-amyloid aggregates in the ECM, 
observations that did not occur in 2D culture or mice (Choi et 
al., 2014). Similarly, scaffold-free 3D neural organoids, but 
not 2D culture, were shown to accumulate amyloid aggregates 
and model tauopathy. Significantly, these signs of human neu-
rodegeneration were spontaneous in patient-derived organoids 
but are often only observed in mice after the expression of 
multiple human transgenes (Raja et al., 2016).
Tissue-level processes. At the tissue level, accumu-
lated molecular damage can manifest in a variety of ways. 
These include changes in tissue function, susceptibility to can-
cer and other diseases, changes in stem cell function, and alter-
ations in the immune system (Aw et al., 2007; López-Otín et al., 
2013; Blau et al., 2015). Encouragingly, a variety of organoid 
models have already been explored to study aspects of each of 
these age-related phenomena.
One feature of aging is a progressive decline in physiolog-
ical function. Various signs of aging, such as lower glomerular 
filtration rate, reduced cardiac output, and increased suscep-
tibility to disease, can often be tied to tissue-specific changes 
that may be more apparent in 3D tissues than 2D culture. For 
example, a semi-enclosed cardiac organoid chamber allows for 
the measurement of pressure and ejection fraction (Lee et al., 
2008). Barrier function can be measured across a kidney- or 
neural-endothelial interface (Vernetti et al., 2017), which could 
be used to model aging-associated declines in glomerular filtra-
tion rate and blood-brain barrier function (Tan et al., 2010; Elahy 
et al., 2015). Additionally, gastrointestinal organoids have been 
used extensively to study host-microbe interactions (Bartfeld et 
al., 2015; Engevik et al., 2015). They would be well-suited to 
studying the aging microbiome and age-related susceptibility to 
disease caused by ordinarily asymptomatic microbes, such as 
Clostridium difficile (Htwe et al., 2007; Heintz and Mair, 2014). 
Age-associated changes in circadian rhythm may also be mod-
eled in organoids, considering that intestinal explants and stem 
cell–derived organoids, but not 2D culture, have been demon-
strated to spontaneously produce robust, synchronized circa-
dian oscillations (Myers and Badia, 1995; Moore et al., 2014). 
In general, organotypic cultures can represent more complex 
and accurate phenotypes than 2D culture and are thus ideal for 
modeling their decline in aging.
Organoids are widespread models for cancer progression 
that have been used to study tumor-initiating mutations and 
processes, such as cancer cell dissemination (Li et al., 2014; 
Nguyen-Ngoc et al., 2015). A natural extension of this work 
would be to use organoids from donors of different ages to un-
derstand how normal, aged tissue responds to in vitro oncogenic 
transformation. For example, transformed human mammary 
epithelial cells develop phenotypes dependent on donor age. 
Aged cells more frequently adopted a luminal-like phenotype 
and expressed estrogen receptor α in organoid culture, sug-
gesting that age is a determinant of cancer subtype (Lee et al., 
2015). In addition, organoid culture permits study of the tumor 
microenvironment, including neighboring cells and the ECM. 
Age-related changes to the microenvironment may play a role 
in altered susceptibility to cancer. Experimental glycation of the 
ECM increased invasiveness and decreased epithelial differen-
tiation in nonmalignant prostate acini (Rodriguez-Teja et al., 
2015). Similarly, the accumulation of senescent cells with age 
may exert tumor-promoting effects on neighboring cells. By co-
culturing fibroblasts with nonmalignant mammary organoids, 
Parrinello et al. (2005) demonstrated that senescent fibroblasts 
secreted factors that increased invasion and proliferation, and 
decreased epithelial differentiation.
Organoids are excellent models for stem cell maintenance 
and tissue repair, because organoids can recreate in vitro the 
minimal unit of a stem cell niche: cells and ECM in an organo-
typic structure (Murrow et al., 2017). Stem cell exhaustion, or 
reduced proliferation and biased differentiation of stem cells, 
contributes to aging in several tissues, and stem cell function 
is a common readout in aging studies (Brack et al., 2007; Pang 
et al., 2011; Garbe et al., 2012). For example, mouse intesti-
nal organoids have been used to study the proliferation and 
differentiation of ISCs in the context of aging research. In one 
study of ISC function, which declines with age, Nalapareddy 
et al. (2017) used organoids from aged mice to determine that 
the aged ISC niche was deficient in Wnt signaling. Exogenous 
Wnt3a supplementation in organoid culture was sufficient to re-
store organoid formation and lobe growth of aged ISCs. Other 
investigators have used organoid-formation assays to study ca-
loric restriction, an intervention shown to have anti-aging ef-
fects in several model organisms, including nonhuman primates 
(Mattison et al., 2017). By combining the Paneth cells and 
ISCs of ad libitum-fed and calorie-restricted mice, Yilmaz et 
al. (2012) demonstrated that Paneth cells from calorie-restricted 
mice were responsible for increasing ISC organoid formation 
and size. The capacity to separate and perturb the contributions 
of individual niche components, such as growth factors and 
accessory cells, during aging and anti-aging interventions in a 
rapid, systematic manner is an important advantage that organ-
oids provide over model organisms.
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Aging of the immune system is characterized by changing 
proportions of immune cells, declining innate immune function, 
and increased chronic inflammation (Aw et al., 2007). To study 
how these factors intersect with age-associated diseases such 
as cancer and osteoarthritis, aging researchers can take advan-
tage of existing methods for studying the effects of immune 
cell co-culture and pro-inflammatory stimuli in organoids. For 
example, co-culture of primary mouse mammary epithelial or-
ganoids and immune cells demonstrated how immune cells reg-
ulate branching morphogenesis (Plaks et al., 2015). Systemic 
inflammation has also been studied in organoids by adding in-
flammatory cytokines or antiinflammatory drugs to the culture 
medium. Anti-inflammatory treatment of intestinal organoids 
suppressed the senescence-associated inflammatory response 
and reduced inflammation-mediated tumorigenesis (Pribluda et 
al., 2013). Sun et al. (2011) used both cytokines and macro-
phage-conditioned media to simulate immune involvement in a 
3D human chondrocyte model of osteoarthritis. In response to 
inflammation, the cartilage scaffolds demonstrated phenotypic 
features of early osteoarthritis, such as increased and atypi-
cal matrix synthesis and degradation. These examples high-
light systems that integrate organoids with immune cells and 
inflammatory cytokines.
Sourcing organoids
Organoids can be derived from several sources, most notably 
primary cells and tissue or pluripotent stem cells (PSCs). Cell 
lines are less suitable sources for most applications of organ-
oids to aging research, because of immortalization, evasion of 
cellular senescence, or tumor origins. In contrast, tissues from 
donors of different ages are a more suitable model of the phe-
notypes of aging. These samples are becoming more readily 
available to the basic science research community. A handful 
of untransformed primary human cell types and tissues, such 
as keratinocytes, stromal and dermal fibroblasts, and mam-
mary epithelial cells, are available from cell banks. Skin, blood, 
marrow, fat, breast, and muscle are relatively abundant tissues 
that can be acquired from healthy donors undergoing elective 
surgery. In addition, primary human material can be obtained 
from pathologically normal tumor-peripheral tissue, surgical 
discards, tissues ineligible for transplant, and trimmings from 
transplanted tissues (Barkauskas et al., 2017).
Fresh, primary tissue explants or fragments can be cul-
tured with minimal processing, often retaining multiple cell 
types and the surrounding donor-derived ECM and stroma 
(Fig. 1 A; Tanos et al., 2013; Nguyen-Ngoc et al., 2015; Li et 
al., 2016). Some, such as arteries, skin, and central nervous 
system, are typically cultured as thin slices; alternatively, or-
ganoids may be derived from fragments of digested minced tis-
sue. Both strategies maintain original tissue structure, minimize 
disruption to cell state, and may include ECM and accessory 
cells. The maintenance of intact paracrine signaling networks 
contributes to the overall function of tissue fragment-derived 
organoids. For example, the stromal compartment in intestinal 
organoids can maintain the stem cell niche without exogenous 
growth factors (Ootani et al., 2009). Similarly, human mam-
mary organoids retaining stromal and ECM elements maintain 
hormone responsiveness and proliferate without exogenous 
growth factors (Tanos et al., 2013). These organoids represent 
the most physiologically relevant in vitro models and can be 
particularly valuable for studying complex, intercellular signal-
ing networks in aging tissue. However, sample size and tissue 
types are limited, and it can be difficult to specifically perturb 
one component or cell type in the system.
In contrast, primary human cells can be dissociated, op-
tionally expanded in culture, and then reconstituted into organ-
oids. These reconstituted organoids allow for expanded cell 
numbers and considerably more control over constituent cells 
and ECM, including the opportunity to perturb specific com-
ponents (Fig. 1 B). Although tissue composition and cell state 
change rapidly on 2D culture, suitable conditions for preserving 
lineage-specific markers during expansion have been identified 
in a variety of tissues, including keratinocytes, fibroblasts, and 
mammary and lung epithelial cells (Wilson et al., 1992; Stamp-
fer et al., 2013; Barkauskas et al., 2017). Lung epithelial cells 
can be expanded in culture and give rise to branched bronchial or 
alveolar organoids (Barkauskas et al., 2017). Human mammary 
epithelial cells are a notable aging resource established from 
surgical discards of donors of different ages and disease status, 
including healthy women and cancer patients (Stampfer et al., 
2013). Nonimmortal mammary epithelial cells can be expanded 
in vitro for several passages, retain transcriptional signatures 
of their source tissue, and recapitulate the bilayered structure 
of the mammary gland in reconstituted organoids (Garbe et al., 
2012; Cerchiari et al., 2015). One caveat is that expansion in 
culture selects for proliferative cells, potentially excluding cells 
with short telomeres, terminally differentiated nonproliferating 
cells, and cells undergoing senescence. Furthermore, 2D culture 
also causes loss of cell type–specific transcriptional profiles; 
some of this dedifferentiation can be reversed or ameliorated on 
transitioning to organotypic culture (Caron et al., 2012).
Primary tissue is also a source of multipotent adult tis-
sue stem cells that can generate organoids in the presence of 
specific growth factors; stem cell–derived organoids are also 
generated from PSCs (Fig. 1 C). Organoids from multiple epi-
thelial tissues, including stomach, small intestine, colon, liver, 
pancreas, breast, and prostate, have been expanded from single 
primary stem or progenitor cells (Table 1). However, an issue 
with this method is that their maintenance requires the inclu-
sion of stem cell niche–maintaining soluble factors, which may 
obscure phenotypes of aging that originate in growth factor 
signaling (Broutier et al., 2016; Nalapareddy et al., 2017). In 
contrast, PSCs, including induced PSCs (iPSCs) and embryonic 
stem cells allow for a greater range of key human tissue types 
than can be practicably supplied by surgical discards, notably 
brain and cardiac muscle. These organoids frequently contain 
multiple cell types and self-organizing tissue structures that 
recapitulate embryonic development. For example, human iP-
SC-derived brain organoids have been used to model early stage 
and developmental disorders (Qian et al., 2016) and could be-
come excellent models for neurodegenerative diseases such as 
Alzheimer’s disease. Raja et al. (2016) demonstrated that iPSC 
organoids derived from patients with familial Alzheimer’s dis-
ease develop robust pathology, including amyloid aggregation, 
hyperphosphorylated tau protein, and endosome abnormalities. 
Caution must be exercised when applying stem cell studies to 
aging research. Although familial disease–linked mutations are 
widely studied, genetic disease may differ mechanistically from 
sporadic, age-related disease. Furthermore, PSCs begin in a fe-
tal-like state and require additional maturation. Many hallmarks 
of aging, aside from somatic mutations, are reverted on iPSC re-
programming, including DNA damage foci, epigenetic marks, 
oxidative damage, senescence markers, and telomere length 
(Horvath, 2013; Cornacchia and Studer, 2017).
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Outlook
Advances in organotypic culture techniques ultimately seek 
to obtain relevant phenotypes in vitro. Remarkable progress 
has been made in developing organoid techniques and culture 
systems, but several limitations remain to be addressed or val-
idated. Furthermore, there are many opportunities to improve 
on the reproducibility and complexity of organoids, particularly 
by the inclusion of tissue engineering and microfluidics. These 
areas of current research are summarized in Table 2.
Although pluripotent stem cells are a significant source 
for organoids, one concern is the immaturity of cells and tis-
sues derived from these cells, because PSCs begin in a fetal-like 
state. Functional and developmental maturation of stem cells is 
an active area of research and has been pursued by techniques 
such as long-term culture, altered concentrations of growth 
factors and inhibitors, direct differentiation, and mechanical 
or electrical stimulation (Chambers et al., 2012; Nicholas et 
al., 2013; Mertens et al., 2015; Ruan et al., 2016; Takasato et 
al., 2016; Tzatzalos et al., 2016). In vivo maturation, typically 
by implantation into a mouse, has also been demonstrated to 
increase organoid maturity and can be used to generate adult-
like human tissue and organoids (Huch et al., 2013; Watson et 
al., 2014; Takebe et al., 2015).
Similarly, accelerated aging in vitro will be necessary for 
PSC-derived organoids and useful for studying the functional 
consequences of age-associated damage. Accelerated aging 
experiments typically involve cells derived from progeric in-
dividuals (Liu et al., 2011; Miller et al., 2013) or expose cells 
to aging-associated stress, such as reactive oxygen species, in-
flammation, or radiation, which appear to phenocopy aspects of 
aging (Nasto et al., 2013; Cornacchia and Studer, 2017). With 
regard to aging experiments, organoid culture, as opposed to 
cell culture, has the advantage of increased stability. This sta-
bility has allowed culture periods as long as 60 wk (Hibiya et 
al., 2017), which can be used to study chronological aging in 
vitro. For example, 120 d of culture of reconstituted human epi-
dermis led to increased cellular senescence and morphological 
changes resembling those of chronological skin aging in vivo 
(Dos Santos et al., 2015). Furthermore, genomic stability has 
been reported to be higher in organoids than in traditional cell 
Figure 1. Types of organoids. (A) Tissue fragments and ex-
plants are generated from native tissue with little disruption 
to cell and ECM organization and no intermediate period 
in 2D culture. This limits total sample size and manipulability 
but is unmatched in mimicking the original tissue. (B) Reconsti-
tuted organoids are assembled in vitro from cultured or sorted 
cells. This permits cell expansion and modular assembly of 
components. However, some subpopulations or phenotypes, 
such as senescent and hormone-responsive cells, may be lost 
during culture. (C) Stem cell–derived organoids are differen-
tiated from multipotent adult tissue stem cells or PSCs under 
the appropriate differentiation and maintenance conditions. 
PSCs specifically can generate rare tissue and cell types, but 
have limited maturity and lose the hallmarks of aging.
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culture, as demonstrated by the use of organoid culture to clon-
ally expand stem cells before mutational analysis (Behjati et al., 
2014; Huch et al., 2015; Blokzijl et al., 2016). Notably, organ-
oid clonal expansion was also used to quantify the accumula-
tion of mutations in adult ISCs with age (Blokzijl et al., 2016).
Primary cell and organoid culture remains highly sen-
sitive to culture conditions. Support of the ISC niche, for ex-
ample, was a revolutionary advance, permitting long-term 
expansion of intestinal organoids that once could be cultured 
for only a couple of weeks (Ootani et al., 2009). Other tissues, 
such as artery or ovary, can still only be cultured for only short 
times. Additionally, aging studies may be particularly sensitive 
to culture conditions. Numerous culture parameters that can 
phenocopy aspects of aging, such as replicative aging, oxygen 
tension, and free glucose, must be carefully controlled for. Fi-
nally, long-term culture and studying tissue homeostasis require 
the maintenance of growth-arrested organoids resembling the 
resting state of adult tissues. Identifying microenvironmental 
conditions to transition organoid tissues from a proliferative to 
a more mature, growth-arrested state would represent an im-
portant contribution to aging research.
As in vitro models increasingly seek to recapitulate com-
plex tissue- and organ-level phenotypes, transport of oxygen 
and nutrients by diffusion becomes limiting. Air–liquid inter-
faces have been used to culture larger explants, but in general, 
vasculature will be necessary for the survival of most organ-
oids over a couple hundred micrometers wide (Auger et al., 
2013), as well as useful for the study of aging-relevant pheno-
types, such as metastasis and deterioration of the blood-brain 
barrier and glomerulus (Tan et al., 2010; Elahy et al., 2015). 
Furthermore, vascularization has the potential to network or-
ganoids into systemic, multiorgan contexts that allow the ex-
change of hormones, cytokines, and metabolites, which have 
been implicated in aging in mice (Villeda et al., 2014). Incor-
poration into a systemic environment presents an opportunity 
to complement the strengths of organoid and in vivo platforms: 
organoids generated and manipulated in vitro can be implanted 
into mice, where they mature and integrate into the host vascu-
lature (Watson et al., 2014; Takebe et al., 2015). Such systems 
could be powerful tools to study the effects of an aged systemic 
environment on human tissues.
Similarly, microfluidics could increase the complexity of 
in vitro organoid systems while improving throughput and repro-
ducibility. Multiorgan systems have been developed for the study 
of organ interactions via an in vivo-like sequential, organ-to-organ 
transfer of media, with a particular interest in drug interactions 
(Vernetti et al., 2017). These devices could provide insight into 
how aging tissues affect other parts of the body. Additionally, mi-
crofluidic devices permit lumen access and control over millime-
ter-scale morphology. Although complex tissue structures, such 
as intestinal crypts and kidney nephrons, are readily generated 
by organoid self-organization (Morizane et al., 2015), the process 
can be highly heterogeneous, making assay readout complex or 
impossible. For example, reproducible kidney organoids with a 
channel-accessible central duct would enable key functional as-
says, namely permeability and urea concentration. Methods for 
micron-scale organization of cells within a tissue or microfluidic 
chamber (Nelson et al., 2008; Todhunter et al., 2015; Kolesky et 
al., 2016) could be used to create reproducible, high-throughput 
organoid assays for aging and other diseases.
Table 1. Examples of rodent and human tissues cultured as organoids
Tissue Type Examples
Tissue fragments Reconstituted Stem cell derived
Central nervous system: brain, 
retina
Human, rat Rat hiPSC, hESC Xiang et al., 2000; van Vliet et al., 2007; Hansen 
et al., 2010; Eiraku et al., 2011; Qian et al., 
2016; Matsui et al., 2017
Gastrointestinal: esophagus, 
stomach, small intestine, 
colon
Human, mouse Human, mouse, hPSC, mESC Ootani et al., 2009; Barker et al., 2010; Sato et 
al., 2011; Bartfeld et al., 2015; Noguchi et al., 
2015; Li et al., 2016
Pancreas Human, mouse Human, mouse, hiPSC Huch et al., 2013; Marciniak et al., 2014; Broutier 
et al., 2016; Hohwieler et al., 2017
Liver Human, mouse Human Human, mouse, hiPSC Messner et al., 2013; Huch et al., 2015; Takebe et 
al., 2015; Broutier et al., 2016
Kidney Mouse Human, mouse hiPSC, hESC Astashkina et al., 2012; Chang and Davies, 2012; 
Freedman et al., 2015; Morizane et al., 2015
Lung Human, mouse Human, mouse hiPSC, mouse Moore et al., 2005; Wu et al., 2010; Barkauskas 
et al., 2013; Dye et al., 2015; Hegab et al., 
2015
Muscle: skeletal, cardiac Human, rat, mouse hiPSC Lee et al., 2008; Madden et al., 2015; Tzatzalos 
et al., 2016
Skin Human Human Stojadinovic et al., 2013; Dos Santos et al., 2015
Cartilage Human Human hMSC Squires et al., 2003; Caron et al., 2012; Lozito et 
al., 2013; Bhumiratana et al., 2014
Artery Rat Human, mouse Belmin et al., 1995; L’Heureux et al., 1998
Mammary gland Human, mouse Human Human Villadsen et al., 2007; Linnemann et al., 2011; 
Tanos et al., 2013; Nguyen-Ngoc et al., 2015
Prostate Human Human, rat Human, mouse Nevalainen et al., 1993; Lang et al., 2001; 
Karthaus et al., 2014
Ovary, endometrium Human Human Kwong et al., 2009; Turco et al., 2017
Thyroid Human mESC Toda et al., 2002; Antonica et al., 2012
Organoid culture has now been extended to a variety of tissues, including many from adult human primary tissue or cells. h, human; m, mouse; MSC, mesenchymal stem cell.
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Organoids are a powerful emerging tool for the study of 
human health and disease. Aging research has long needed a 
model with the practical advantages of simpler organisms and 
traditional cell culture, as well as the complexity required to 
model the tissue-level phenotypes that accompany aging. As 
researchers develop organotypic cultures of increasing com-
plexity, it is becoming clear that organoids will enable the 
study of tissue-level, and even systems-level, phenotypes of 
aging. Human organoids have the potential to model the human 
body with unmatched fidelity. With time, new models will be 
Table 2. Summary of current limitations and areas for development in organoid culture for aging
Goals Approaches Challenges
Increase developmental maturity 
of pluripotent stem cell–derived 
organoids
Long-term culture (Nicholas et al., 2013; Takasato et al., 2016; 
Tzatzalos et al., 2016)
Stem cells are highly sensitive to culture conditions, 
impeding robust protocols
In vivo maturation (Huch et al., 2013; Watson et al., 2014; Takebe 
et al., 2015)
Mechanical or electrical conditioning of muscle and cartilage 
(Ruan et al., 2016)
Improved culture conditions and differentiation protocols
Acceleration by small molecules (Chambers et al., 2012)
Source culturable, age-varied human 
cells
Surgical discards from elective surgery, transplant trimmings, and 
tissue peripheral to tumors
Hard to source certain tissues, especially healthy, 
culturable adult cells
Cells adapt to culture and are not infinitely renewable
Nontumor peripheral tissue may differ from healthy 
tissue
In vitro aging to model the effects of 
specific age-related lesions and 
provide a source of artificially 
aged cells
Induced senescence by DNA damage or environmental stress 
(Busuttil et al., 2003; Parrinello et al., 2005; Nasto et al., 2013)
Controversial which treatments best phenocopy aging
Long-term culture (Dos Santos et al., 2015)
Progeria mutations (Liu et al., 2011; Zhang et al., 2011; Miller et 
al., 2013)
Direct reprogramming of aged cells (Mertens et al., 2015)
Mimic the effects of the aged ECM 
in vitro
ECM from aged donors (Gullapalli et al., 2005; Williams et al., 
2014; Stearns-Reider et al., 2017)
Controversial which treatments best phenocopy aging
Glycation crosslinking (Rodriguez-Teja et al., 2015) ECM extraction from tissues can alter its mechanical 
properties, microstructure, and composition
Enzymatic crosslinking (Levental et al., 2009)
Develop aging-relevant experimental 
readouts
Epigenetic clock (Hannum et al., 2013; Horvath, 2013) Unclear which signs of aging are most important
Mutational analysis (Blokzijl et al., 2016) Require signs of aging that change appreciably 
across the span of an experiment
Protein/DNA oxidation
Protein aggregation
Tissue-specific functional assays
Long-term maintenance of organoids 
in a stable, growth-arrested state
Improved culture media Relatively few published maintenance conditions
Improved ECM and bioreactors Vetting culture conditions is lengthy
Complete modeling of whole organs 
and physiological systems
Co-culture with immune cells, stromal cells, and microbiome bacteria 
(Parrinello et al., 2005; Engevik et al., 2015; Plaks et al., 2015)
Few good techniques for sophisticated organoid 
construction
Increase throughput and 
reproducibility
Vascularization (Auger et al., 2013) Powerful techniques are often cumbersome and 
low-throughput
Innervation (Workman et al., 2017)
In vivo implantation (Watson et al., 2014; Takebe et al., 2015)
Microfluidic access to apical/basal fluid reservoirs and fluid 
transport between organ systems (Vernetti et al., 2017)
Organ-specific ECM (Voytik-Harbin et al., 2007; Zhang et al., 
2009; O’Brien et al., 2010)
Defined artificial ECMs may decrease lot-to-lot variability (Gjorevski 
et al., 2016)
Growth factor distribution within ECM gels for spatial control over 
growth and differentiation (Wylie et al., 2011)
Cell patterning for control over initial organoid shape and 
composition (Nelson et al., 2008; Todhunter et al., 2015)
3D-printed gels amenable to perfusion with control over large-scale 
tissue structure (Kolesky et al., 2016)
Morphological screening and sorting to enrich for correctly formed 
organoids (Arora et al., 2017)
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developed and validated, significantly accelerating human 
aging research and the search for therapies that will improve 
human health and lifespan.
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